Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sangamo Therapeutics's price to sales ratio was 0.9× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 25.6×, with a median of 3.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.9× | −2.2 |
| 2025 | Dec 31, 2025 | 3.2× | −0.6 |
| 2024 | Dec 31, 2024 | 3.8× | +3.3 |
| 2023 | Dec 29, 2023 | 0.5× | −3.7 |
| 2022 | Dec 30, 2022 | 4.2× | −5.7 |
| 2021 | Dec 31, 2021 | 9.9× | −3.7 |
| 2020 | Dec 31, 2020 | 13.6× | +1.3 |
| 2019 | Dec 31, 2019 | 12.2× | −4.3 |
| 2018 | Dec 31, 2018 | 16.5× | −26.0 |
| 2017 | Dec 29, 2017 | 42.6× | +31.6 |
| 2016 | Dec 30, 2016 | 11.0× | −3.1 |
| 2015 | Dec 31, 2015 | 14.1× | −13.4 |
| 2014 | Dec 31, 2014 | 27.5× | −5.1 |
| 2013 | Dec 31, 2013 | 32.6× | +14.4 |
| 2012 | Dec 31, 2012 | 18.2× | +3.7 |
| 2011 | Dec 30, 2011 | 14.5× | – |
See a number that looks wrong?